This implies that in the context of bulk RNA-seq, CTLA4 levels function primarily as a surrogate marker for the density of tumor-infiltrating lymphocytes rather than reflecting tumor-intrinsic signaling alone. This evidence concerns the gene CTLA4 and neoplasm.